Author:
Ribed Almudena,Romero-Jiménez Rosa María,Escudero-Vilaplana Vicente,Iglesias-Peinado Irene,Herranz-Alonso Ana,Codina Carlos,Sanjurjo-Sáez Maria
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pharmaceutical Science,Pharmacology,Toxicology,Pharmacy
Reference24 articles.
1. Partridge AH, Avorn J, Wang PS, Winer EP. Adherence to therapy with oral antineoplastic agents. J Natl Cancer Inst. 2002;94:652–61.
2. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, et al. GLOBOCAN 2012 v1.0, cancer incidence and mortality worldwide: IARC cancerbase no. 11 [Internet]. Lyon. France: International Agency for Research on Cancer; 2013. http://globocan.iarc.fr .
3. Neuss MN, Polovich M, McNiff K, Esper P, Gilmore TR, LeFebvre KB, et al. 2013 updated American Society of Clinical Oncology/Oncology Nursing Society chemotherapy administration safety standards including standards for the safe administration and management of oral chemotherapy. J Oncol Pract. 2013;9(2 Suppl.):S5–13.
4. Aisner J. Overview of the changing paradigm in cancer treatment: oral chemotherapy. Am J Health Syst Pharm. 2007;64:4–7.
5. Institute for Safe Medications Practices. ISMP’s list of high-alert medications. Huntingdon Valley: ISMP; 2014. http://www.ismp.org/tools/highalertmedications.pdf (Accessed 27 Jan 2015).